Epidermal growth factor: internal duplication and probable relationship to pancreatic secretory trypsin inhibitor.

Suppr

超能文献

作者信息

Hunt L T, Barker W C, Dayhoff M O

出版信息

Biochem Biophys Res Commun. 1974 Oct 8;60(3):1020-8. doi: 10.1016/0006-291x(74)90415-x.

DOI:10.1016/0006-291x(74)90415-x

PMID:4429557

Abstract

摘要

相似文献

Epidermal growth factor: internal duplication and probable relationship to pancreatic secretory trypsin inhibitor.

Biochem Biophys Res Commun. 1974 Oct 8;60(3):1020-8. doi: 10.1016/0006-291x(74)90415-x.

Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.

J Mol Biol. 1974 Oct 15;89(1):73-101. doi: 10.1016/0022-2836(74)90163-6.

The involvement of an arginine residue of trypsin in its interaction with the Kunitz soybean trypsin inhibitor.

Biochim Biophys Acta. 1973 Apr 20;303(2):274-83. doi: 10.1016/0005-2795(73)90358-9.

The single-disulphide intermediates in the refolding of reduced pancreatic trypsin inhibitor.

J Mol Biol. 1974 Aug 15;87(3):603-24. doi: 10.1016/0022-2836(74)90106-5.

Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells.

Res Commun Chem Pathol Pharmacol. 1986 Aug;53(2):245-8.

Isolation and partial characterization of the pancreatic secretory trypsin inhibitor in the rat.

Biochim Biophys Acta. 1982 Jul 16;717(1):91-7. doi: 10.1016/0304-4165(82)90384-1.

Molecular cloning and characterization of genes encoding rat pancreatic cholecystokinin (CCK)-releasing peptide (monitor peptide) and pancreatic secretory trypsin inhibitor (PSTI).

Biochim Biophys Acta. 1992 Sep 24;1132(2):199-202. doi: 10.1016/0167-4781(92)90012-o.

[On modification of the specific trypsin inhibitor from porcine pancreas during inhibition by trypsin].

Hoppe Seylers Z Physiol Chem. 1967 Sep;348(9):1216-8.

The multiplicity of human pancreatic secretory trypsin inhibitor.

J Biochem. 1985 Sep;98(3):687-94. doi: 10.1093/oxfordjournals.jbchem.a135326.

Isolation and characterization of a new form of the porcine pancreatic secretory trypsin inhibitor. Biochemical studies and high-resolution 1H-NMR.

Biochim Biophys Acta. 1982 Sep 22;707(1):50-8. doi: 10.1016/0167-4838(82)90395-8.

引用本文的文献

SPINKs in Tumors: Potential Therapeutic Targets.

Front Oncol. 2022 Feb 11;12:833741. doi: 10.3389/fonc.2022.833741. eCollection 2022.

Bad Tumors Made Worse: SPINK1.

Front Cell Dev Biol. 2019 Feb 4;7:10. doi: 10.3389/fcell.2019.00010. eCollection 2019.

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.

Oncotarget. 2015 Nov 3;6(34):35737-54. doi: 10.18632/oncotarget.5927.

A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.

Tumour Biol. 2014 Mar;35(3):2759-67. doi: 10.1007/s13277-013-1366-y. Epub 2013 Nov 13.

Role of Intrapancreatic SPINK1/Spink3 Expression in the Development of Pancreatitis.

Front Physiol. 2012 May 7;3:126. doi: 10.3389/fphys.2012.00126. eCollection 2012.

Therapeutic targeting of SPINK1-positive prostate cancer.

Sci Transl Med. 2011 Mar 2;3(72):72ra17. doi: 10.1126/scitranslmed.3001498.

Protease activity in protein-free NS0 myeloma cell cultures.

In Vitro Cell Dev Biol Anim. 2005 Nov-Dec;41(10):330-6. doi: 10.1007/s11626-005-0004-4.

A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cells.

Biochem J. 1993 Apr 1;291 ( Pt 1)(Pt 1):57-63. doi: 10.1042/bj2910057.

Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.

Int J Pancreatol. 1994 Feb;15(1):65-73. doi: 10.1007/BF02924389.

Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon.

Am J Pathol. 1995 Feb;146(2):310-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验